Earnings History Data for Forte Biosciences (FBRX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Forte Biosciences
Forte Biosciences Inc. is a clinical stage, dermatology company. It engages in developing biotherapeutic, FB-401, for the treatment of inflammatory skin diseases which is in clinical stage. Forte Biosciences Inc., formerly known as Tocagen Inc., is based in Sherman Oaks, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | FBRX | Forte Biosciences | 8.00 | -4.54 | -6.75 | 0.00 | Forte Biosciences GAAP EPS of -$4.54 [11/15/2024 5:14 AM] |
5.55 | -0.03 (-0.54%) |
5.56 | -0.02 (-0.36%) |
4.11 - 21.25 | 10,918 | 10,000 | 239 | ||
| 14-08-2024 | AH | FBRX | Forte Biosciences | 15.00 | -0.27 | -0.16 | 0.00 | 0.3055 | -0.08 (-21.67%) |
0.40 | 0.01 (2.46%) |
0.28 - 0.91 | 1,586,766 | 30,000 | 484 | |||
|
|
||||||||||||||||||
| 13-11-2023 | PM | FBRX | Forte Biosciences, Inc. | 17.60 | -0.26 | 0.00 | -0.18 | Forte Biosciences GAAP EPS of -$0.26 [11/14/2023 1:45 AM] |
0.39 | -0.04 (-9.49%) |
0.41 | -0.02 (-4.85%) |
0.38 - 1.29 | 91,119 | 20,000 | 1,907 | ||
| 14-11-2022 | PM | FBRX | Forte Biosciences, Inc. | 20.34 | -0.18 | 0.00 | -0.54 | Forte Biosciences GAAP EPS of -$0.18 misses by $0.03 [11/15/2022 6:13 AM] |
0.9950 | -0.02 (-1.49%) |
0.99 | -0.02 (-1.98%) |
0.90 - 3.38 | 30,552 | 40,000 | 1,133 | ||
| 10-05-2021 | AH | 4:05 PM ET (May 10) |
FBRX | Forte Biosciences, Inc. | 432.28 | -0.36 | -0.39 | -6.45 | Forte Biosciences EPS beats by $0.17 [5/10/2021 4:38 PM] |
32.47 | 0.72 (2.27%) |
33.45 | 0.81 (2.48%) |
13.35 - 53.99 | 107,087 | 120,000 | 153 | |
| 24-03-2021 | PM | FBRX | Forte Biosciences, Inc. | 384.46 | N/A | -0.49 | -6.60 | Forte Biosciences reports Q4 results [3/24/2021 8:34 AM] |
24.71 | -2.93 (-10.60%) |
29.00 | 1.36 (4.92%) |
13.35 - 53.99 | 334,954 | 320,000 | 7,061 | ||
| 09-11-2020 | AH | 4:00 PM ET (Nov 9) |
FBRX | Forte Biosciences, Inc. | 432.47 | -0.46 | -0.32 | -11.69 | Forte Biosciences reports Q3 results [11/9/2020 4:52 PM] |
34.22 | -0.70 (-2.00%) |
0.0 | 0.0 (0.00%) |
6.33 - 53.99 | 39,117 | 91,790 | 0 | |
|
|
||||||||||||||||||
| 10-08-2020 | AH | After the close (Aug 10) |
FBRX | Forte Biosciences, Inc. | 0.00 | -9.52 | 0.00 | -10.79 | 20.13 | -2.08 (-9.37%) |
22.22 | 0.01 (0.04%) |
6.33 - 73.65 | 52,025 | 47,988 | 1,510 | ||
|
|
||||||||||||||||||